+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
Verapamil (CAS 52-53-9) Global Market Research Report 2024 - Product Thumbnail Image

Verapamil (CAS 52-53-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Warfarin (CAS 81-81-2) Global Market Research Report 2024 - Product Thumbnail Image

Warfarin (CAS 81-81-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Zofenopril (CAS 81872-10-8) Global Market Research Report 2024 - Product Thumbnail Image

Zofenopril (CAS 81872-10-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
a-Escin (CAS 6805-41-0) Global Market Research Report 2024 - Product Thumbnail Image

a-Escin (CAS 6805-41-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more